- Home
- J vs PCVX Comparison
J vs PCVX Comparison
Compare J & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- J
- PCVX
- Stock Information
- Founded
- J 1947
- PCVX 2013
- Country
- J United States
- PCVX United States
- Employees
- J N/A
- PCVX N/A
- Industry
- J Military/Government/Technical
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- J Industrials
- PCVX Health Care
- Exchange
- J Nasdaq
- PCVX Nasdaq
- Market Cap
- J 16.4B
- PCVX 13.2B
- IPO Year
- J N/A
- PCVX 2020
- Fundamental
- Price
- J $140.00
- PCVX $86.51
- Analyst Decision
- J Buy
- PCVX Strong Buy
- Analyst Count
- J 12
- PCVX 7
- Target Price
- J $159.30
- PCVX $147.50
- AVG Volume (30 Days)
- J 663.9K
- PCVX 1.4M
- Earning Date
- J 11-19-2024
- PCVX 11-05-2024
- Dividend Yield
- J 0.83%
- PCVX N/A
- EPS Growth
- J N/A
- PCVX N/A
- EPS
- J 5.07
- PCVX N/A
- Revenue
- J $16,948,610,000.00
- PCVX N/A
- Revenue This Year
- J N/A
- PCVX N/A
- Revenue Next Year
- J $20.85
- PCVX N/A
- P/E Ratio
- J $27.56
- PCVX N/A
- Revenue Growth
- J 6.30
- PCVX N/A
- 52 Week Low
- J $100.84
- PCVX $48.24
- 52 Week High
- J $150.54
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- J 47.45
- PCVX 23.31
- Support Level
- J $146.37
- PCVX $101.87
- Resistance Level
- J $150.54
- PCVX $107.31
- Average True Range (ATR)
- J 2.89
- PCVX 5.82
- MACD
- J -0.66
- PCVX -2.04
- Stochastic Oscillator
- J 9.53
- PCVX 3.58
About J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $16.4 billion in revenue and $1.3 billion in adjusted operating income in fiscal 2023.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.